1994
DOI: 10.1016/0022-1759(94)90126-0
|View full text |Cite
|
Sign up to set email alerts
|

Detection of cell specific cluster determinant expression by reverse transcriptase polymerase chain reaction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

1995
1995
2004
2004

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 16 publications
(10 citation statements)
references
References 10 publications
0
10
0
Order By: Relevance
“…Expression of the CD genes in Pal‐1 cells was also examined by RT‐PCR essentially as previously described (James‐Yarish et al , 1994). The primer sequences specific for CD2, CD3‐γ, CD7, CD19 and CD20 genes were obtained from GenBank and a previous report (James‐Yarish et al , 1994). The experiments were controlled by the use of two cell lines, BALL‐1 (B‐cell leukaemia) (Hiraki et al , 1977) and TALL‐1 (T‐cell leukaemia) (Hiraki et al , 1978).…”
Section: Resultsmentioning
confidence: 99%
“…Expression of the CD genes in Pal‐1 cells was also examined by RT‐PCR essentially as previously described (James‐Yarish et al , 1994). The primer sequences specific for CD2, CD3‐γ, CD7, CD19 and CD20 genes were obtained from GenBank and a previous report (James‐Yarish et al , 1994). The experiments were controlled by the use of two cell lines, BALL‐1 (B‐cell leukaemia) (Hiraki et al , 1977) and TALL‐1 (T‐cell leukaemia) (Hiraki et al , 1978).…”
Section: Resultsmentioning
confidence: 99%
“…13 The CD4 ϩ CD28 null phenotype was further confirmed by reversetranscriptase polymerase chain reaction (RT-PCR) analysis of mRNA for the CD4 and CD28 markers using primers for CD4 (5Ј-TGGCTCTGGAAACCTCACCCT-3Ј and 5Ј-GGCACTGGCAGG-TCTTCTTCT-3Ј) and CD28 (5Ј-GTTTGAGTGCCTTGATCATGT-GC-3Ј and 5Ј-GGCGATCTGCTTCACCAAAATC-3Ј). 14,15 Blocking MHC Class I and II Antigen Presentation MHC-restricted antigen presentation was assessed by incubating the PBMCs with blocking antibodies for 40 minutes at room temperature before antigen stimulation. The antibodies used were 10 g/mL of anti-human MHC-class I (HLA A, B, and C; Dako), anti-human CD4, anti-human MHC class II (HLA DR, DP, DQ), or a combination of both anti-CD4 and anti-human class II antibodies (Becton Dickinson).…”
Section: Reverse-transcriptase Polymerase Chain Reactionmentioning
confidence: 99%
“…PBMCs were used as positive controls. The primers used for PCR were as follows; CD25, forward 5Ј-ACAACCAATGTCAATGCACAAGCT-3Ј and reverse 5Ј-TCTGTTCCCGGCTTCTTACCAAGA-3Ј [19]; CD122, forward 5Ј-CCGTGGCTCGGCCACCTC-3Ј and reverse 5Ј-TAGGGGTCGTAAGTA-AAGTACACC-3Ј [13]; CD132, forward 5Ј-CCAGGACCCACGGGAACCCA-3Ј and reverse 5Ј-GGTGGGAATTCGGGGCATCG-3Ј [11]; and human glyceraldehyde-3-phosphate dehydrogenase (GAPDH), forward 5Ј-TGAAGGTCG-GAGTCAACGGATTTGGT-3Ј and reverse 5Ј-CATGTGGGCCAATGAGGTC-CACCAC-3Ј [4]. The primers for CD25, CD122, CD132, and GAPDH were constructed to generate fragments of 634/419, 437, 493, and 983 bp, respectively.…”
Section: Reverse Transcriptase-polymerase Chain Reaction (Rt-pcr)mentioning
confidence: 99%